Feedback / Questions
NGC-capecitabine (PCS6422) - Processa Pharma
https://www.globenewswire.com/news-release/2024/04/11/2861459/0/en/Processa-Pharmaceuticals-Presents-Two-Abstracts-at-the-AACR-Annual-Meeting-2024-Including-New-Data-on-the-NGC-Cap-Phase-1b-Trial.html
Apr 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next